Parvus Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch Parvus Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of PVT401 in Healthy Subjects (NCT07423000) | Parvus Therapeutics, Inc. | 2026-04-01 |
| Single Ascending Dose Study to Evaluate Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of PVT201 in Healthy Subjects and Patients (PBC/PSC) (NCT06798454) | Parvus Therapeutics, Inc. | 2024-10-15 |
Track Parvus Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.